ELI
CELG

Empire Life Investments’s Celgene Corp CELG Stock Holding History

Empire Life Investments’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-295,391
Closed -$29.3M – 108
2019
Q3 		$29.3M Buy
295,391
+17,731
+6% +$1.68M 2.46% 12
2019
Q2 		$25.7M Buy
277,660
+3,128
+1% +$297K 2.07% 16
2019
Q1 		$25.9M Sell
274,532
-146,555
-35% -$12.8M 2.17% 14
2018
Q4 		$27M Buy
421,087
+96,236
+30% +$7.1M 2.43% 10
2018
Q3 		$29.1M Sell
324,851
-21,119
-6% -$1.87M 2.22% 10
2018
Q2 		$27.5M Buy
345,970
+1,648
+0.5% +$137K 1.98% 13
2018
Q1 		$30.7M Buy
344,322
+99,311
+41% +$9.53M 2.18% 8
2017
Q4 		$25.6M Buy
245,011
+174,056
+245% +$19.6M 1.97% 15
2017
Q3 		$10.3M Buy
70,955
+40,322
+132% +$5.49M 0.84% 47
2017
Q2 		$3.98M Buy
+30,633
New +$3.75M 0.35% 71

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Empire Life Investments's CELG Position: Q4 2019 in Review

Empire Life Investments sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 295,391 shares — an estimated $29.3M sold.

Empire Life Investments first reported a position in CELG in Q2 2017 and held it in 10 quarters. The position peaked at $30.7M in Q1 2018. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Empire Life Investments reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Empire Life Investments sold 295,391 Celgene Corp shares in Q4 2019, an estimated $29.3M.
  • Empire Life Investments first reported a position in Celgene Corp in Q2 2017 and held it in 10 quarters.
  • Empire Life Investments's Celgene Corp position peaked at $30.7M in Q1 2018.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Empire Life Investments's 13F filing for Q4 2019, filed 21 Jan 2020.